Success Metrics

Clinical Success Rate
77.8%

Based on 14 completed trials

Completion Rate
78%(14/18)
Active Trials
10(30%)
Results Posted
0%(0 trials)
Terminated
4(12%)

Phase Distribution

Ph not_applicable
9
27%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
N/ANon-phased studies
9(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

77.8%

14 of 18 finished

Non-Completion Rate

22.2%

4 ended early

Currently Active

10

trials recruiting

Total Trials

33

all time

Status Distribution
Active(12)
Completed(14)
Terminated(4)
Other(3)

Detailed Status

Completed14
Recruiting8
Terminated4
unknown3
Not yet recruiting2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
33
Active
10
Success Rate
77.8%
Most Advanced
N/A

Trials by Phase

N/A9 (100.0%)

Trials by Status

not_yet_recruiting26%
unknown39%
completed1442%
active_not_recruiting26%
terminated412%
recruiting824%

Recent Activity

Clinical Trials (33)

Showing 20 of 33 trialsScroll for more
NCT07500324Not Applicable

Proteomic Biomarker Identification in AMD, Diabetic Retinopathy and Retinal Detachment

Recruiting
NCT03228459Not Applicable

The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease

Active Not Recruiting
NCT07483476

Study of Cell-free DNA in Children and Adolescents With Acute Lymphoblastic Leukemia

Not Yet Recruiting
NCT04873492Not Applicable

From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis

Recruiting
NCT07398430

Metabolic Characteristics and Prognostic Model of Acute Coronary Syndrome Complicated With Obstructive Sleep Apnea

Not Yet Recruiting
NCT05772767Not Applicable

Modulation of Ciliogenesis in Glioma Stem Cells

Completed
NCT06350539

Personalized Models for Cancer Research

Recruiting
NCT06203106

NYSCF Scientific Discovery Biobank

Recruiting
NCT05536388

Drug Discovery for Parkinson's With Mutations in the GBA Gene

Recruiting
NCT06203093

Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for IPSC Generation and Biobanking

Recruiting
NCT04455308Not Applicable

COVID-19 and Chilblains

Completed
NCT06068738

Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer

Terminated
NCT05537909Not Applicable

Role of Gut Microbiota in the Pathophysiology of Aseptic Abscesses

Recruiting
NCT04270604

Biological Sample Collection for Research and Biobanking

Terminated
NCT05787964

Immunity to Infection in Healthy Participants and Participants With Cancer

Active Not Recruiting
NCT06372054

TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models

Recruiting
NCT05246774

Study of Serum and Urinary Biomarkers and Radiation Cystitis in Patients Treated With Radiotherapy for Localized Prostate Cancer

Unknown
NCT01099852

Cohort of Patients Infected by an Arbovirus

Unknown
NCT05772741Not Applicable

Grafts of GSCs Into Brain Organoids for Testing Anti-invasion Drugs

Unknown
NCT04698161

Establishment of the Human Intestinal and Salivary Microbiota Biobank - Oncologic Diseases

Completed

Drug Details

Intervention Type
OTHER
Total Trials
33